Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma
This report, which includes a summary of each presentation, reviews the findings presented at the workshop and highlights opportunities, open questions, and areas for future study that would pave the way for a cure for this disease in the coming decades.PMID:38421601 | DOI:10.46883/2024.25921013 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - February 29, 2024 Category: Cancer & Oncology Authors: Lymphoma Research Foundation Lymphoma Research Foundation Source Type: research
Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma
This report, which includes a summary of each presentation, reviews the findings presented at the workshop and highlights opportunities, open questions, and areas for future study that would pave the way for a cure for this disease in the coming decades.PMID:38421601 | DOI:10.46883/2024.25921013 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - February 29, 2024 Category: Cancer & Oncology Authors: Lymphoma Research Foundation Lymphoma Research Foundation Source Type: research
Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma
This report, which includes a summary of each presentation, reviews the findings presented at the workshop and highlights opportunities, open questions, and areas for future study that would pave the way for a cure for this disease in the coming decades.PMID:38421601 | DOI:10.46883/2024.25921013 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - February 29, 2024 Category: Cancer & Oncology Authors: Lymphoma Research Foundation Lymphoma Research Foundation Source Type: research
Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma
This report, which includes a summary of each presentation, reviews the findings presented at the workshop and highlights opportunities, open questions, and areas for future study that would pave the way for a cure for this disease in the coming decades.PMID:38421601 | DOI:10.46883/2024.25921013 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - February 29, 2024 Category: Cancer & Oncology Authors: Lymphoma Research Foundation Lymphoma Research Foundation Source Type: research
Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma
This report, which includes a summary of each presentation, reviews the findings presented at the workshop and highlights opportunities, open questions, and areas for future study that would pave the way for a cure for this disease in the coming decades.PMID:38421601 | DOI:10.46883/2024.25921013 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - February 29, 2024 Category: Cancer & Oncology Authors: Lymphoma Research Foundation Lymphoma Research Foundation Source Type: research
Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma
This report, which includes a summary of each presentation, reviews the findings presented at the workshop and highlights opportunities, open questions, and areas for future study that would pave the way for a cure for this disease in the coming decades.PMID:38421601 | DOI:10.46883/2024.25921013 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - February 29, 2024 Category: Cancer & Oncology Authors: Lymphoma Research Foundation Lymphoma Research Foundation Source Type: research
Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma
This report, which includes a summary of each presentation, reviews the findings presented at the workshop and highlights opportunities, open questions, and areas for future study that would pave the way for a cure for this disease in the coming decades.PMID:38421601 | DOI:10.46883/2024.25921013 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - February 29, 2024 Category: Cancer & Oncology Authors: Lymphoma Research Foundation Lymphoma Research Foundation Source Type: research
Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma
This report, which includes a summary of each presentation, reviews the findings presented at the workshop and highlights opportunities, open questions, and areas for future study that would pave the way for a cure for this disease in the coming decades.PMID:38421601 | DOI:10.46883/2024.25921013 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - February 29, 2024 Category: Cancer & Oncology Authors: Lymphoma Research Foundation Lymphoma Research Foundation Source Type: research
Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma
This report, which includes a summary of each presentation, reviews the findings presented at the workshop and highlights opportunities, open questions, and areas for future study that would pave the way for a cure for this disease in the coming decades.PMID:38421601 | DOI:10.46883/2024.25921013 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - February 29, 2024 Category: Cancer & Oncology Authors: Lymphoma Research Foundation Lymphoma Research Foundation Source Type: research
Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma
This report, which includes a summary of each presentation, reviews the findings presented at the workshop and highlights opportunities, open questions, and areas for future study that would pave the way for a cure for this disease in the coming decades.PMID:38421601 | DOI:10.46883/2024.25921013 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - February 29, 2024 Category: Cancer & Oncology Authors: Lymphoma Research Foundation Lymphoma Research Foundation Source Type: research
Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma
This report, which includes a summary of each presentation, reviews the findings presented at the workshop and highlights opportunities, open questions, and areas for future study that would pave the way for a cure for this disease in the coming decades.PMID:38421601 | DOI:10.46883/2024.25921013 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - February 29, 2024 Category: Cancer & Oncology Authors: Lymphoma Research Foundation Lymphoma Research Foundation Source Type: research
Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma
This report, which includes a summary of each presentation, reviews the findings presented at the workshop and highlights opportunities, open questions, and areas for future study that would pave the way for a cure for this disease in the coming decades.PMID:38421601 | DOI:10.46883/2024.25921013 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - February 29, 2024 Category: Cancer & Oncology Authors: Lymphoma Research Foundation Lymphoma Research Foundation Source Type: research
Case report: From sequence to solution: tailoring treatment for transformed follicular lymphoma (DLBCL) through next generation sequencing study
This report serves as a testament to the ever-evolving landscape of cancer treatment, where precision medicine and immunotherapy continue to unlock new possibilities for those confronting the most challenging malignancies. (Source: Frontiers in Oncology)
Source: Frontiers in Oncology - February 29, 2024 Category: Cancer & Oncology Source Type: research
Solar ultraviolet radiation exposure, and incidence of childhood acute lymphocytic leukaemia and non-Hodgkin lymphoma in a US population-based dataset
British Journal of Cancer, Published online: 29 February 2024; doi:10.1038/s41416-024-02629-3Solar ultraviolet radiation exposure, and incidence of childhood acute lymphocytic leukaemia and non-Hodgkin lymphoma in a US population-based dataset (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 29, 2024 Category: Cancer & Oncology Authors: Mark P. Little Jim Z. Mai Michelle Fang Pavel Chernyavskiy Victoria Kennerley Elizabeth K. Cahoon Myles G. Cockburn Gerald M. Kendall Michael G. Kimlin Source Type: research
A US Multicenter Collaborative Study on Outcomes of Hematopoietic Cell Transplantation in Hepatosplenic T-Cell Lymphoma
Hepatosplenic T-cell lymphoma (HSTCL) is an extremely rare subtype of non-Hodgkin lymphoma (NHL) accounting for less than 1% of cases.1-3 HSTCL was first described in 1981 and included as a provisional entity in the revised European-American classification of lymphoid neoplasms in 1994.4,5 Subsequently, HSTCL was recognized as a separate entity in the World Health Organization (WHO) classification of lymphoid malignancies in 1999.6 (Source: Biology of Blood and Marrow Transplantation)
Source: Biology of Blood and Marrow Transplantation - February 29, 2024 Category: Hematology Authors: Muhamad Alhaj Moustafa, Jeremy L Ramdial, Athanasios Tsalatsanis, Farhad Khimani, Bhagirathbhai Dholaria, Leyla Bojanini, Taylor Brooks, Jasmine Zain, N. Nora Bennani, Zachary Braunstein, Jonathan E. Brammer, Amer Beitinjaneh, Deepa Jagadeesh, Wen Kai Wen Source Type: research
